ORCA
Online Research @ CardiffÂ
Browse by Current Cardiff authors
![[up]](/style/images/multi_up.png)
Up a levelNumber of items: 2.
Murphy, Alexander D, Porter, Catharine  ORCID: https://orcid.org/0000-0003-1851-0677, White, Ann, Irving, Alys, Adams, Richard ORCID: https://orcid.org/0000-0003-3915-7243, Ray, Ruby, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Mahmood, Reem D., Karanth, Suman, Zhou, Cong, Pugh, Julia, Wheeler, Chelsey, Roberts, Victoria, Arnetoli, Giorgio, Salih, Zena, Hasan, Jurjees, Mitchell, Claire, Morgan, Robert D., Clamp, Andrew R. and Jayson, Gordon C.
2024.
Once daily cediranib and weekly paclitaxel to prevent malignant bowel obstruction in at-risk patients with platinum-resistant ovarian cancer (CEBOC): a single-arm, phase II safety trial.
International Journal of Gynecological Cancer
34
, pp. 1034-1040.
10.1136/ijgc-2024-005455
|
|
Fennell, Dean A., Porter, Catharine ORCID: https://orcid.org/0000-0003-1851-0677, Lester, Jason, Danson, Sarah, Blackhall, Fiona, Nicolson, Marianne, Nixon, Lisette ORCID: https://orcid.org/0000-0002-1270-6970, Gardner, Georgina, White, Ann, Griffiths, Gareth and Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052
2022.
Olaparib maintenance versus placebo monotherapy in patients with advanced non-small cell lung cancer (PIN): A multicentre, randomised, controlled, phase 2 trial.
EClinicalMedicine
52
, 101595.
10.1016/j.eclinm.2022.101595
|
|
|
Cardiff University Information Services